Bill > S2294

This bill reauthorizes and updates the Kay Hagan Tick Act, which addresses research and support for tick-borne diseases. The bill makes two key changes to existing law: first, it modifies the language around who can be consulted in developing a national strategy for vector-borne diseases by removing a specific reference to the Tick-Borne Disease Working Group and instead using the more general phrase "appropriate individuals"; second, it adjusts funding levels for two key programs. For the National Strategy and Regional Centers of Excellence in Vector-Borne Disease program, the bill reduces the annual funding from $10 million to $8 million and extends the funding period through fiscal year 2030. For the program providing enhanced support to health departments in addressing vector-borne diseases, the bill reduces annual funding from $20 million to $19 million for fiscal years 2026 through 2030. These changes aim to continue supporting research and public health efforts related to tick-borne diseases while making slight adjustments to funding levels.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/2294/all-info